 |
|
Peripartum Cardiomyopathy
National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop Recommendations and Review
Gail D. Pearson, MD, ScD;
Jean-Claude Veille, MD;
Shahbudin Rahimtoola, MD;
Judith Hsia, MD;
Celia M. Oakley, MD;
Jeffrey D. Hosenpud, MD;
Aftab Ansari, MD;
Kenneth L. Baughman, MD
JAMA. 2000;283:1183-1188.
Objective Peripartum cardiomyopathy (PPCM) is a rare life-threatening cardiomyopathy of unknown cause that occurs in the peripartum period in previously healthy women. In April 1997, the National Heart, Lung, and Blood Institute (NHLBI) and the Office of Rare Diseases of the National Institutes of Health (NIH) convened a Workshop on Peripartum Cardiomyopathy to foster a systematic review of information and to develop recommendations for research and education.
Participants Fourteen workshop participants were selected by NHLBI staff and represented cardiovascular medicine, obstetrics, immunology, and pathology. A representative subgroup of 8 participants and NHLBI staff formed the writing group for this article and updated the literature on which the conclusions were based. The workshop was an open meeting, consistent with NIH policy.
Evidence Data presented at the workshop were augmented by a MEDLINE search for English-language articles published from 1966 to July 1999, using the terms peripartum cardiomyopathy, cardiomyopathy, and pregnancy. Articles on the epidemiology, pathogenesis, pathophysiology, diagnosis, treatment, and prognosis of PPCM were included.
Recommendation Process After discussion of data presented, workshop participants agreed on a standardized definition of PPCM, a general clinical approach, and the need for a registry to provide an infrastructure for future research.
Conclusions Peripartum cardiomyopathy is a rare lethal disease about which little is known. Diagnosis is confined to a narrow period and requires echocardiographic evidence of left ventricular systolic dysfunction. Symptomatic patients should receive standard therapy for heart failure, managed by a multidisciplinary team. If subsequent pregnancies occur, they should be managed in collaboration with a high-risk perinatal center. Systematic data collection is required to answer important questions about incidence, treatment, and prognosis.
Author Affiliations: Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Dr Pearson); Department of Obstetrics and Gynecology, Bowman Gray School of Medicine, Winston-Salem, NC (Dr Veille); Division of Cardiology, University of Southern California, Los Angeles (Dr Rahimtoola); Division of Cardiology, George Washington University School of Medicine and Health Sciences, Washington, DC (Dr Hsia); Emeritus Professor of Cardiology, Imperial College Medical School, London, England (Dr Oakley); Division of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee (Dr Hosenpud); Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Ga (Dr Ansari); and Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Md (Dr Baughman).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
African-American Women Have a Higher Risk for Developing Peripartum Cardiomyopathy
Gentry et al.
J Am Coll Cardiol 2010;55:654-659.
ABSTRACT
| FULL TEXT
Cardiomyopathy and anaesthesia
Davies and Cousins
Contin Educ Anaesth Crit Care Pain 2009;9:189-193.
FULL TEXT
Heart failure in women: a need for prospective data.
Hsich and Pina
J Am Coll Cardiol 2009;54:491-498.
ABSTRACT
| FULL TEXT
Peripartum cardiomyopathy: Causes, diagnosis, and treatment
RAMARAJ and SORRELL
Cleveland Clinic Journal of Medicine 2009;76:289-296.
ABSTRACT
| FULL TEXT
Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy
de Jong et al.
Eur J Heart Fail 2009;11:220-222.
ABSTRACT
| FULL TEXT
Reversal of IFN-{gamma}, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy
Forster et al.
Eur J Heart Fail 2008;10:861-868.
ABSTRACT
| FULL TEXT
Stroke in pregnancy and the puerperium
Treadwell et al.
Postgrad. Med. J. 2008;84:238-245.
ABSTRACT
| FULL TEXT
Stroke and pregnancy
Davie and O'Brien
J. Neurol. Neurosurg. Psychiatry 2008;79:240-245.
ABSTRACT
| FULL TEXT
Hypertrophy signaling during peripartum cardiac remodeling
Gonzalez et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H3008-H3013.
ABSTRACT
| FULL TEXT
Extracorporeal Membrane Oxygenation in a Patient With Peripartum Cardiomyopathy
Yang et al.
Ann. Thorac. Surg. 2007;84:262-264.
ABSTRACT
| FULL TEXT
Cardiac disease in pregnancy. Part 2: acquired heart disease
Gelson et al.
The Obstetrician and Gynaecologist 2007;9:83-87.
ABSTRACT
| FULL TEXT
Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy
Hu et al.
Heart 2007;93:488-490.
ABSTRACT
| FULL TEXT
Brief Communication: Outcomes of Subsequent Pregnancy after Peripartum Cardiomyopathy: A Case Series from Haiti
Fett et al.
ANN INTERN MED 2006;145:30-34.
ABSTRACT
| FULL TEXT
Manifestations of Chronic Disease During Pregnancy
Kaaja and Greer
JAMA 2005;294:2751-2757.
ABSTRACT
| FULL TEXT
Five-Year Prospective Study of the Incidence and Prognosis of Peripartum Cardiomyopathy at a Single Institution
Fett et al.
Mayo Clin Proc. 2005;80:1602-1606.
ABSTRACT
Peripartum cardiomyopathy (PPCM) in both surrogate and biological mother
Fett
Hum Reprod 2005;20:2666-2668.
FULL TEXT
Pregnancy-Associated Cardiomyopathy: Clinical Characteristics and a Comparison Between Early and Late Presentation
Elkayam et al.
Circulation 2005;111:2050-2055.
ABSTRACT
| FULL TEXT
A mother's heartache: peripartum cardiomyopathy
Heart 2005;91:552-552.
FULL TEXT
Postnatal pre-cordial pain. Pulmonary embolism or peripartum cardiomyopathy
Quinn et al.
Emerg. Med. J. 2004;21:746-747.
FULL TEXT
Recognition and management of maternal cardiac disease in pregnancy
Ray et al.
Br J Anaesth 2004;93:428-439.
ABSTRACT
| FULL TEXT
Pregnancy in heart disease
Thorne
Heart 2004;90:450-456.
FULL TEXT
Successful Use of Levosimendan in a Patient with Peripartum Cardiomyopathy
Benlolo et al.
Anesth. Analg. 2004;98:822-824.
ABSTRACT
| FULL TEXT
Pregnant again after peripartum cardiomyopathy: to be or not to be?
Elkayam
Eur Heart J 2002;23:753-756.
FULL TEXT
Women, Heart Failure, and Heart Failure Therapies
Wenger
Circulation 2002;105:1526-1528.
FULL TEXT
Peripartum Cardiomyopathy: Clinical and Therapeutic Aspects
Mehta et al.
ANGIOLOGY 2001;52:759-762.
ABSTRACT
CONGENITAL HEART DISEASE: Heart disease and pregnancy
Siu and Colman
Heart 2001;85:710-715.
FULL TEXT
Maternal and Fetal Outcomes of Subsequent Pregnancies in Women with Peripartum Cardiomyopathy
Elkayam et al.
NEJM 2001;344:1567-1571.
ABSTRACT
| FULL TEXT
Peripartum Cardiomyopathy
Reimold and Rutherford
NEJM 2001;344:1629-1630.
FULL TEXT
Underlying Causes and Survival in Patients with Heart Failure
Givertz
NEJM 2000;342:1120-1122.
FULL TEXT
|
